eprintid: 90955 rev_number: 1 eprint_status: archive userid: 1 dir: disk0/00/09/09/55 datestamp: 2026-05-26 16:27:39 lastmod: 2026-05-26 16:27:39 status_changed: 2026-05-26 16:27:39 type: article metadata_visibility: show sword_depositor: 1 creators_name: Ostonov, Samandar creators_name: Nasullayev, Fayzi title: HYPERTHYROIDISM AND ATRIAL FIBRILLATION IN WOMEN OVER 40: RISK FACTORS AND MANAGEMENT STRATEGIES ispublished: pub subjects: Hyperthyroidism, Atrial fibrillation, Thyrotoxic arrhythmia, Women cardiovascular health, Middle-aged women, Subclinical hyperthyroidism, CHA₂DS₂-VASc score, Thyroid hormone cardiac effects, Anticoagulation in hyperthyroidism, Graves’ disease and AF keywords: Hyperthyroidism, Atrial fibrillation, Thyrotoxic arrhythmia, Women cardiovascular health, Middle-aged women, Subclinical hyperthyroidism, CHA₂DS₂-VASc score, Thyroid hormone cardiac effects, Anticoagulation in hyperthyroidism, Graves’ disease and AF note: Imported from Universal Publishings (OAI id oai:ojs.pkp.sfu.ca:article/11009) abstract: Hyperthyroidism, characterized by excessive thyroid hormone production, is a well-established risk factor for atrial fibrillation (AF), particularly in women over 40. This article reviews the pathophysiological mechanisms, epidemiological data, and evidence-based management approaches for AF in hyperthyroid patients, with a focus on middle-aged and older women. We analyze key studies and clinical guidelines to provide a comprehensive overview of this critical cardiovascular-endocrine interaction. date: 2025-04-19 date_type: published publisher: Research Science and Innovation House official_url: https://universalpublishings.com/index.php/jassh/article/view/11009 id_number: oai:ojs.pkp.sfu.ca:article/11009 full_text_status: none publication: JOURNAL OF ANALYTICAL SYNERGY AND SCIENTIFIC HORIZON citation: Ostonov, Samandar, Nasullayev, Fayzi (2025) HYPERTHYROIDISM AND ATRIAL FIBRILLATION IN WOMEN OVER 40: RISK FACTORS AND MANAGEMENT STRATEGIES. JOURNAL OF ANALYTICAL SYNERGY AND SCIENTIFIC HORIZON.